Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irreversible Electroporation for Benign Prostatic Obstruction
NCT03448510Phase 2Unknown
- Sponsor
- Changhai Hospital
- Start
- Apr 2018
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Changhai Hospital. Primary endpoint: Maximum Flow Rate at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT03448510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03448510.